| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |